Monte Rosa Therapeutics, Inc. (GLUE)

Latest Insider Confidence Score

2026Q1

53.9
Bullish

Company insider confidence (by quarter)

2021Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Versant Venture Capital VI, L.P. 10% Owner 1,573,453 Oct 30, 2024
Versant Ventures VI GP, L.P. 10% Owner 1,573,453 Oct 30, 2024
Versant Ventures VI GP-GP, LLC 10% Owner 1,573,453 Oct 30, 2024
Versant Vantage I, L.P. 10% Owner 1,573,453 Oct 30, 2024
Versant Vantage I GP, L.P. 10% Owner 1,573,453 Oct 30, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 5, 2026 Dunn Edmund Principal Accounting Officer Sell 50.0 -139 -0.61% ✗ $2.5K
Mar 2, 2026 Mar 4, 2026 Warmuth Markus CEO Sell 48.8 -5,466 -0.88% ✓ $98K
Feb 27, 2026 Mar 2, 2026 Dunn Edmund Principal Accounting Officer Sell 20.0 -25,700 -36.15% ✗ $464.9K
Feb 23, 2026 Feb 24, 2026 Janku Filip Chief Medical Officer Sell 22.5 -9,189 -12.25% ✗ $179.2K
Jan 7, 2026 Jan 9, 2026 Warmuth Markus CEO Sell 48.8 -5,466 -0.88% ✓ $128.4K
Jan 2, 2026 Jan 5, 2026 Nickson Philip Chief Business & Legal Officer Sell 91.3 +24,845 69.01% ✗ $47.9K
Jan 2, 2026 Jan 5, 2026 Champoux Jennifer COO Sell 91.3 +32,371 107.90% ✗ $39.9K
Jan 5, 2026 Jan 5, 2026 Dunn Edmund Principal Accounting Officer Sell 46.3 -1,039 -4.38% ✗ $15.8K
Jan 2, 2026 Jan 5, 2026 Warmuth Markus CEO Sell 95.0 +79,865 14.67% ✗ $153.7K
Jan 2, 2026 Jan 5, 2026 Janku Filip Chief Medical Officer Sell 91.3 +27,845 59.02% ✗ $47.9K
Jan 2, 2026 Jan 5, 2026 Townson Sharon Chief Scientific Officer Sell 91.3 +31,845 88.46% ✗ $47.9K
Jun 13, 2025 Jun 16, 2025 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 Hughes Eric A Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 Manning Anthony M. Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 Blackwell Kimberly Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 Siu Christine Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 Skvarka Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 SCHIFF ANDREW N Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 4, 2025 Dunn Edmund Principal Accounting Officer Sell 47.5 -2,062 -7.99% ✗ $9.2K
Mar 24, 2025 Mar 25, 2025 Leo Chandra P. Director Buy 95.0 +10,000 100.00% ✗ $58.4K
Jan 2, 2025 Jan 6, 2025 Nickson Philip Chief Business & Legal Officer Neutral 90.0 +36,000 100.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Dunn Edmund Principal Accounting Officer Neutral 90.0 +11,850 84.98% ✗ -
Jan 2, 2025 Jan 6, 2025 Janku Filip Chief Medical Officer Neutral 90.0 +36,000 391.77% ✗ -
Jan 2, 2025 Jan 6, 2025 Champoux Jennifer COO Neutral 90.0 +30,000 100.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Warmuth Markus CEO Neutral 90.0 +128,000 30.73% ✗ -
Jan 2, 2025 Jan 6, 2025 Townson Sharon Chief Scientific Officer Neutral 90.0 +36,000 100.00% ✗ -
Dec 11, 2024 Dec 13, 2024 Hughes Eric A Director Neutral 52.5 - 0.00% ✗ -
Dec 13, 2024 Hughes Eric A Director Neutral 52.5 - 0.00% ✗ -
Oct 28, 2024 Oct 30, 2024 Versant Venture Capital VI, L.P. 10% Owner Sell 17.5 -1,544,352 -12.37% ✗ $1.5M
Sep 20, 2024 Sep 24, 2024 Versant Venture Capital VI, L.P. 10% Owner Sell 16.3 -1,132,566 -13.60% ✗ $7.4M
Sep 11, 2024 Sep 13, 2024 Versant Venture Capital VI, L.P. 10% Owner Sell 17.5 -567,213 -6.38% ✗ $3.4M
Sep 13, 2024 Sep 13, 2024 Janku Filip Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 5, 2024 Jul 9, 2024 Dunn Edmund Principal Accounting Officer Sell 47.5 -1,610 -10.35% ✗ $6.2K
Jun 12, 2024 Jun 13, 2024 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 SCHIFF ANDREW N Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Skvarka Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Siu Christine Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Manning Anthony M. Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Blackwell Kimberly Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2024 Jun 5, 2024 Dunn Edmund Principal Accounting Officer Sell 47.5 -1,207 -7.20% ✗ $4.9K
Jun 3, 2024 Jun 5, 2024 Nickson Philip Chief Business & Legal Officer Neutral 52.5 - 0.00% ✗ -
Jun 3, 2024 Jun 5, 2024 Townson Sharon Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 3, 2024 Jun 5, 2024 Champoux Jennifer COO Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Champoux Jennifer COO Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Townson Sharon Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Warmuth Markus CEO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Wallace Owen B. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Jones Jullian G Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Janku Filip Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Dunn Edmund Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Nickson Philip General Counsel Neutral 52.5 - 0.00% ✗ -
Aug 18, 2023 Dunn Edmund Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jul 25, 2023 Jul 26, 2023 Manning Anthony M. Director Neutral 52.5 - 0.00% ✗ -
Jul 26, 2023 Manning Anthony M. Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Skvarka Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Siu Christine Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 SCHIFF ANDREW N Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Mayweg Alexander Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Blackwell Kimberly Director Neutral 52.5 - 0.00% ✗ -
Mar 30, 2023 Mar 31, 2023 Skvarka Jan Director Neutral 52.5 - 0.00% ✗ -
Mar 24, 2023 Skvarka Jan Director Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Wallace Owen B. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Warmuth Markus CEO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Nickson Philip General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Townson Sharon Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Jones Jullian G Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Castle John C. Chief Data Scientist Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Tamboli Ajim CFO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 4, 2023 Janku Filip Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 15, 2022 Dec 19, 2022 Janku Filip Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 31, 2022 Nov 1, 2022 Janku Filip Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Jun 16, 2022 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Jun 16, 2022 Siu Christine Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Jun 16, 2022 SCHIFF ANDREW N Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Jun 16, 2022 Mayweg Alexander Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2022 Jun 16, 2022 Blackwell Kimberly Director Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Jones Jullian G Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Tamboli Ajim CFO Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Janku Filip Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Townson Sharon Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Nickson Philip General Counsel Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Castle John C. Chief Data Scientist Neutral 52.5 - 0.00% ✗ -
Mar 2, 2022 Nickson Philip General Counsel Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Wallace Owen B. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Mar 2, 2022 Warmuth Markus CEO Neutral 52.5 - 0.00% ✗ -
Dec 2, 2021 Jones Julian G Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jun 28, 2021 Jun 30, 2021 Yang Rick 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Walker Paul Edward 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Sonsini Peter W. 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 SANDELL SCOTT D 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Mathers Edward T 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 MAKOWER JOSHUA 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Makhzoumi Mohamad 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Landsman Liza 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Florence Anthony A. Jr. 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Chang Carmen 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 Behbahani Ali Director Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 BASKETT FOREST 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M
Jun 28, 2021 Jun 30, 2021 New Enterprise Associates 17, L.P. 10% Owner Buy 100.0 +1,050,000 15.81% ✗ $20M